AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitapril M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ajanta Pharma Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitapril M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo may be used independently or in conjunction with other anti-diabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and existing medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial for successful diabetes management; lifestyle choices are integral to controlling your condition. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for all individuals. Prior to initiating treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Drug interactions are possible; disclose all medications to your physician to ensure safety. Alcohol should be minimized due to its potential to reduce blood glucose levels. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitapril M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Sitapril M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sitapril M 50mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Sitapril M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitapril M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Sitapril M 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitapril M 50mg/500mg Tablet works:

Sitagliptin/metformin 50mg/500mg tablets (Sitapril M) combine two medications to manage blood glucose. Sitagliptin stimulates increased insulin production by the pancreas, enhances insulin effectiveness, and reduces hepatic glucose output. Metformin, a biguanide, works by decreasing liver glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity. This dual action leads to more effective blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Sitapril M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitapril M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitapril M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitapril M 50mg/500mg tablets, potentially requiring dosage modification. A physician's consultation is necessary. For individuals with severe kidney disease, Sitapril M 50mg/500mg tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitapril M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitapril M 50mg/500mg Tablet :

Should you forget to take a Sitapril M 50mg/500mg Tablet, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitapril M 50mg/500mg Tablet

LabelValue
Addictive None.
Treatment Category Medication for diabetes

FAQs on Sitapril M 50mg/500mg Tablet

Sitagliptin/Metformin 50mg/500mg tablets (Sitapril M) combine two active ingredients to manage type 2 diabetes. This medication helps regulate blood sugar in adults when used with a healthy diet and physical activity. Metformin reduces glucose production by the liver and enhances insulin responsiveness. Sitagliptin blocks the DPP4 enzyme, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Indeed, prolonged use of Sitapril M 50mg/500mg Tablets can lead to Vitamin B12 deficiency. This medication impairs the body's absorption of Vitamin B12 within the gastrointestinal tract. Consequently, untreated deficiency can manifest as anemia and neurological complications, potentially causing symptoms such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Taking Sitapril M 50mg/500mg tablets may result in common side effects such as low blood sugar, taste changes, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Serious, though infrequent, side effects include lactic acidosis. Prolonged use could also cause vitamin B12 deficiency.
Patients with hypersensitivity to Sitapril M 50mg/500mg Tablet constituents or inactive ingredients should not take this medication. Similarly, its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitapril M 50mg/500mg Tablet is unsafe and may elevate the risk of lactic acidosis.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any unused medication appropriately. Prevent access by children, pets, and others.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Sitagliptin/Metformin and prompt medical attention.
Sitagliptin/Metformin 50mg/500mg tablets (Sitapril M) combine two active ingredients to manage type 2 diabetes. This medication helps regulate blood sugar in adults when used with a healthy diet and exercise program. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Sitagliptin blocks DPP-4 enzyme activity, stimulating increased insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Taking Sitapril M 50mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitapril M 50mg/500mg Tablet constituents or inactive ingredients should not take this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitapril M 50mg/500mg tablets is unsafe due to the heightened risk of lactic acidosis.
Indeed, Sitapril M 50mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this infrequent adverse reaction linked to metformin necessitates avoidance in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Indeed, prolonged administration of Sitapril M 50mg/500mg tablets can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Consequently, untreated deficiency may result in anemia and neurological complications, potentially manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive alterations, and gait instability. Prophylactic supplementation with Vitamin B12, at least annually, is recommended by some investigators to mitigate these risks.
Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, animals, and others.
Sitagliptin and Metformin, combined as Sitapril M 50mg/500mg tablets, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a balanced diet and exercise program. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin works by suppressing DPP-4 enzyme activity, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitapril M 50mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis can occur. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitapril M 50mg/500mg Tablet constituents or inactive ingredients should not take this medication. This medicine is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitapril M 50mg/500mg tablets is unsafe due to the heightened risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction necessitates avoidance in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms might include muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Indeed, prolonged Sitapril M 50mg/500mg Tablet consumption can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Left unaddressed, this deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive alterations, and gait instability. To mitigate these risks, some studies recommend supplemental Vitamin B12 at least annually.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure the medicine remains inaccessible to children, pets, and other individuals.
Sitapril M 50mg/500mg Tab...
233
MRP 270
13% off